Tag: pharma operations

Understanding Line Clearance Lapses During Unplanned Downtime: A Risk Assessment Approach The occurrence of line clearance lapses during unplanned downtime in pharmaceutical manufacturing can pose significant risks to product quality,…

Investigating Hold Time Exceedances During Unplanned Downtime in Pharmaceutical Manufacturing In pharmaceutical manufacturing, exceeding established hold times during unplanned downtimes can trigger significant operational challenges, including non-conformance with GMP regulations.…

Addressing Uncontrolled Process Changes During Night Shift Operations: Investigation Ownership and Documentation Uncontrolled process changes during night shift operations can lead to significant deviations in pharmaceutical manufacturing, potentially affecting product…

“`html Addressing Batch Record Discrepancies on the Shop Floor: Ownership and Documentation Strategies A batch record discrepancy on the shop floor can present significant challenges for pharmaceutical operations, impacting production…